Medical News

RSS

Canadian Red Cross ramps up relief efforts in flood ravaged Pakistan

The Canadian Red Cross is ramping up relief efforts in flood ravaged Pakistan. A Red Cross distribution planned for Sunday will put much-needed emergency supplies into the hands of 400 families in the SWAT valley. The supplies, funded by Canadian donations, will include tents, blankets and hygiene kits.

13 Aug 2010

Management of therapy-resistant schizophrenia

The psychotic symptoms of up to 30% of schizophrenic patients do not respond adequately to treatment with antipsychotic drugs, other than clozapine. These refractory patients are generally among the most disabled of all people with schizophrenia and require special assessment and treatment.

13 Aug 2010

PROFIT magazine ranks Prollenium as one of Canada's Fastest Growing Companies

Ario Khoshbin, President of Prollenium Medical Technologies Inc., a privately held specialty medical device company, reported today that his firm will continue to record strong year on year gains in revenues and profitability for its 2010 Fiscal Year ending June 30th. Over the past five years, Prollenium has recorded aggregate revenue growth of more than 524% ranking it amongst Canada's fastest growing firms.

13 Aug 2010

THN President applauds FTC, State enforcement officials for crackdown on insurance scammers

Betty Heiman, Founder and President of Transparent Health Network, praised the announcement made today that the FTC and State enforcement officials will crackdown on scammers who target uninsured, unemployed and uninsurable individuals by peddling fraudulent medical discount plans. These plans, according to government officials, are marketed as health insurance but possess few or none of the features either of insurance or of actual plans.

13 Aug 2010

U.S. FDA purchases more licenses to Simulations Plus' DDDPlus software

Simulations Plus, Inc., a leading provider of software for pharmaceutical discovery and development, today announced that it has received a purchase order from the U.S. Food and Drug Administration to expand the number of licenses for the Company's DDDPlus™ simulation software.

13 Aug 2010

SANUWAVE second-quarter revenues decrease to $117,000

SANUWAVE Health, Inc., an emerging medical technology company focused on regenerative medicine, today reported financial results for the three and six months ended June 30, 2010 and provided a business update.

13 Aug 2010

Validare achieves national certification from ACCME for medical education program

Validare has been awarded national certification for their continuing medical education program. The training that Validare provides to physicians and their staff on how to become accredited for Office Based Surgery has now been recognized by the ACCME. Physicians who participate in Validare's accreditation preparation program will receive CME credits for the time they spend working on becoming accredited for office based surgery.

13 Aug 2010

Soligenix’s net loss for second-quarter 2010 decreases to $1,577,000

Soligenix, Inc., a late-stage biopharmaceutical company, announced today its financial results for the second quarter of 2010.

13 Aug 2010

LabCorp announces collaboration between Esoterix Clinical Trials Services, Clearstone Central Laboratories

Laboratory Corporation of America Holdings announced today a collaboration between Esoterix Clinical Trials Services, a division of LabCorp, and Clearstone Central Laboratories, a global central laboratory specializing in drug development and pharmaceutical services.

13 Aug 2010

CeNeRx BioPharma raises $13 million through Series C financing to support TriRima Phase II trial

CeNeRx BioPharma, Inc., a clinical stage company developing and commercializing innovative treatments for diseases of the central nervous system (CNS), today announced completion of a $13 million Series C financing. Existing investors Perseus Soros Biopharmaceutical Fund, L Capital Partners and Pappas Ventures all participated in the financing. CeNeRx plans to use the proceeds to conduct a Phase II trial of its improved formulation of its novel antidepressant TriRima™.

13 Aug 2010

Catalyst second-quarter net loss decreases to $1,328,541

Catalyst Pharmaceutical Partners, Inc. today announced its financial results for the second quarter and six months ended June 30, 2010.

13 Aug 2010

CRF announces additional featured trials to be presented at Transcatheter Cardiovascular Therapeutics 2010

The Cardiovascular Research Foundation has announced that in addition to the previously announced late breaking clinical trials and first reports, a series of additional featured trials will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 scientific symposium. These trials will focus on a wide range of significant topics in interventional cardiovascular medicine. TCT 2010 will take place September 21 - 25 in Washington, DC.

13 Aug 2010

Trubion Pharmaceuticals signs definitive merger agreement with Emergent BioSolutions

Trubion Pharmaceuticals, Inc. today announced the signing of a definitive merger agreement with Emergent BioSolutions Inc., in which Emergent has agreed to acquire Trubion. Under the terms of the agreement, each share of Trubion common stock will be converted into the right to receive an upfront payment of $1.365 per share in cash and 0.1641 shares of Emergent BioSolutions common stock.

13 Aug 2010

Health 2.0 Developer Challenge initiative announces four new challenges

The Health 2.0 Developer Challenge, an initiative designed to stimulate new innovative application development and data use, announces its four newest challenges which include prize money of over $15,000.

13 Aug 2010

ISW calls upon states to consider community-based programs as treatment for sex offenders

A recent analysis conducted by the Associated Press revealed that the 20 states with civil commitment laws will spend nearly $500 million in 2010 to incarcerate only 5,000 offenders. According to experts at the Boston-based Institute for Sexual Wellness (ISW), states concerned with how to pay for these programs over the long term should investigate community-based programs. Not only are such programs available at a fraction of the cost of civil commitment, but they are demonstrating high success in preventing recidivism.

13 Aug 2010

Challenges in interrelated disciplines of information governance in effective e-Health systems

According to a new report from Accenture, healthcare organizations planning large investments in e-health solutions face challenges in five interrelated disciplines of information governance - data privacy, confidentiality, security, quality and integrity.

13 Aug 2010

MDS Nordion extends cobalt-60 long-term supply agreement with Ontario Power Generation

MDS Nordion, a leading provider of products and services to the global health science market, today announced it has extended its existing agreement with Ontario Power Generation Inc., the Canadian-based electricity generation company, until 2020 for the secure supply of cobalt-60 used in gamma sterilization technologies around the world.

13 Aug 2010

Pro-Pharmaceuticals second-quarter net loss applicable to common stock decreases to $2.5 million

Pro-Pharmaceuticals, Inc., a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today reported its financial results for the second quarter and the first six months ended June 30, 2010. These results are included in the Company's Quarterly Report on Form 10-Q, which has been filed with the SEC.

13 Aug 2010

Medical Facilities second-quarter revenue decreases 1.9% to $51.2 million

Medical Facilities Corporation today reported its financial results for the three- and six-month periods ended June 30, 2010.

13 Aug 2010

Derma Sciences second-quarter net sales increase 14% to $13.2 million

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today reported financial and operating results for the three and six months ended June 30, 2010.

13 Aug 2010

Medical News

Canadian Red Cross ramps up relief efforts in flood ravaged Pakistan

Management of therapy-resistant schizophrenia

PROFIT magazine ranks Prollenium as one of Canada's Fastest Growing Companies

THN President applauds FTC, State enforcement officials for crackdown on insurance scammers

U.S. FDA purchases more licenses to Simulations Plus' DDDPlus software

SANUWAVE second-quarter revenues decrease to $117,000

Validare achieves national certification from ACCME for medical education program

Soligenix’s net loss for second-quarter 2010 decreases to $1,577,000

LabCorp announces collaboration between Esoterix Clinical Trials Services, Clearstone Central Laboratories

CeNeRx BioPharma raises $13 million through Series C financing to support TriRima Phase II trial

Catalyst second-quarter net loss decreases to $1,328,541

CRF announces additional featured trials to be presented at Transcatheter Cardiovascular Therapeutics 2010

Trubion Pharmaceuticals signs definitive merger agreement with Emergent BioSolutions

Health 2.0 Developer Challenge initiative announces four new challenges

ISW calls upon states to consider community-based programs as treatment for sex offenders

Challenges in interrelated disciplines of information governance in effective e-Health systems

MDS Nordion extends cobalt-60 long-term supply agreement with Ontario Power Generation

Pro-Pharmaceuticals second-quarter net loss applicable to common stock decreases to $2.5 million

Medical Facilities second-quarter revenue decreases 1.9% to $51.2 million

Derma Sciences second-quarter net sales increase 14% to $13.2 million

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News